Searched for: in-biosketch:true
person:shauka01
Optimal Approach to Colorectal Cancer Screening
Wang, Christina; Shaukat, Aasma
Rates of colorectal cancer (CRC) screening in the United States continue to fall short of guideline-recommended benchmarks. Challenges to increasing CRC screening include racial disparities, barriers at multiple levels of the health care system, and inadequate completion of 2-step screening. With new options for CRC screening and employment of programmatic strategies for screening by physicians, patients will have more opportunities to initiate and complete testing, which can ultimately improve CRC detection and prevention. This article highlights the current state of and optimal approach to CRC screening.
PMCID:11920019
PMID: 40115656
ISSN: 1554-7914
CID: 5813702
Development of a prognostic risk model for colorectal cancer and association of the prognostic model with cancer stem cell and immune cell infiltration
Zhang, Jian; Ambe, Peter C; Shaukat, Aasma
BACKGROUND/UNASSIGNED:The development of a prognostic model for patients with colorectal cancer (CRC) can facilitate the assessment of patient survival and the effectiveness of clinical treatments. A reasonable prognostic model can provide a basis for individualized treatment, prognostic risk stratification, and subsequent therapy for CRC patients. The aim of our study was to construct a prognostic model for patients with CRC using sequencing data derived from The Cancer Genome Atlas (TCGA) database. METHODS/UNASSIGNED:Sequencing data of paracancerous tissues (n=51) and CRC samples (n=647) were downloaded from the TCGA database. Least absolute shrinkage and selection operator (LASSO) and Cox regression analyses were employed to identify prognostic factors. A restricted cubic spline (RCS) model was used to assess the nonlinear relationship between risk score and poor overall survival (OS). The Genomics of Drug Sensitivity in Cancer (GDSC) database was accessed to evaluate the correlation between the prognostic model's risk score and drug sensitivity. The single-sample gene set enrichment analysis (ssGSEA), estimate, and CIBERSORT algorithms were applied to quantify the association between prognostic genes and immune cell infiltration in CRC. RESULTS/UNASSIGNED:) (HR =1.55; 95% CI: 1.09-2.20; P=0.02) function as independent prognostic factors for CRC. Based on these six genes, the developed prognostic assessment model identified a strong association between high risk score and poor OS (HR =2.43; 95% CI: 1.67-3.53; P<0.001) in patients with CRC. Furthermore, the analysis revealed a nonlinear relationship (P<0.001) between continuous variation in risk score and the risk of poor OS. Additionally, specific genes included in the prognostic model were found to be strongly associated with cancer stem cell and immune cell infiltration in CRC. CONCLUSIONS/UNASSIGNED:We developed a prognostic risk model incorporating a six-gene panel for patients with CRC. Our analysis revealed a nonlinear relationship between this prognostic model and OS in patients with CRC. A high risk score was associated with poor prognosis, indicating that the adverse outcomes observed in patients with CRC may be influenced by cancer stem cell and immune cell infiltration. Our model provides a promising predictive method for the prognosis of CRC patients, but it still needs to be validated in a larger sample size.
PMCID:11921271
PMID: 40115909
ISSN: 2078-6891
CID: 5813712
Advanced Adenoma and Long-Term Risk of Colorectal Cancer, Cancer-Related Mortality, and Mortality
Shaukat, Aasma; Goffredo, Paolo; Wolf, Jack M; Rudser, Kyle; Church, Timothy R
PMCID:11826353
PMID: 39946134
ISSN: 2574-3805
CID: 5793812
Sex Differences in Long COVID
Shah, Dimpy P; Thaweethai, Tanayott; Karlson, Elizabeth W; Bonilla, Hector; Horne, Benjamin D; Mullington, Janet M; Wisnivesky, Juan P; Hornig, Mady; Shinnick, Daniel J; Klein, Jonathan D; Erdmann, Nathaniel B; Brosnahan, Shari B; Lee-Iannotti, Joyce K; Metz, Torri D; Maughan, Christine; Ofotokun, Ighovwerha; Reeder, Harrison T; Stiles, Lauren E; Shaukat, Aasma; Hess, Rachel; Ashktorab, Hassan; Bartram, Logan; Bassett, Ingrid V; Becker, Jacqueline H; Brim, Hassan; Charney, Alexander W; Chopra, Tananshi; Clifton, Rebecca G; Deeks, Steven G; Erlandson, Kristine M; Fierer, Daniel S; Flaherman, Valerie J; Fonseca, Vivian; Gander, Jennifer C; Hodder, Sally L; Jacoby, Vanessa L; Kotini-Shah, Pavitra; Krishnan, Jerry A; Kumar, Andre; Levy, Bruce D; Lieberman, David; Lin, Jenny J; Martin, Jeffrey N; McComsey, Grace A; Moukabary, Talal; Okumura, Megumi J; Peluso, Michael J; Rosen, Clifford J; Saade, George; Shah, Pankil K; Sherif, Zaki A; Taylor, Barbara S; Tuttle, Katherine R; Urdaneta, Alfredo E; Wallick, Julie A; Wiley, Zanthia; Zhang, David; Horwitz, Leora I; Foulkes, Andrea S; Singer, Nora G; ,
IMPORTANCE/UNASSIGNED:A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long COVID, especially within different subgroups, is uncertain. OBJECTIVE/UNASSIGNED:To evaluate sex differences in the risk of developing long COVID among adults with SARS-CoV-2 infection. DESIGN, SETTING, AND PARTICIPANTS/UNASSIGNED:This cohort study used data from the National Institutes of Health (NIH) Researching COVID to Enhance Recovery (RECOVER)-Adult cohort, which consists of individuals enrolled in and prospectively followed up at 83 sites in 33 US states plus Washington, DC, and Puerto Rico. Data were examined from all participants enrolled between October 29, 2021, and July 5, 2024, who had a qualifying study visit 6 months or more after their initial SARS-CoV-2 infection. EXPOSURE/UNASSIGNED:Self-reported sex (male, female) assigned at birth. MAIN OUTCOMES AND MEASURES/UNASSIGNED:Development of long COVID, measured using a self-reported symptom-based questionnaire and scoring guideline at the first study visit that occurred at least 6 months after infection. Propensity score matching was used to estimate risk ratios (RRs) and risk differences (95% CIs). The full model included demographic and clinical characteristics and social determinants of health, and the reduced model included only age, race, and ethnicity. RESULTS/UNASSIGNED:Among 12 276 participants who had experienced SARS-CoV-2 infection (8969 [73%] female; mean [SD] age at infection, 46 [15] years), female sex was associated with higher risk of long COVID in the primary full (RR, 1.31; 95% CI, 1.06-1.62) and reduced (RR, 1.44; 95% CI, 1.17-1.77) models. This finding was observed across all age groups except 18 to 39 years (RR, 1.04; 95% CI, 0.72-1.49). Female sex was associated with significantly higher overall long COVID risk when the analysis was restricted to nonpregnant participants (RR, 1.50; 95%: CI, 1.27-1.77). Among participants aged 40 to 54 years, the risk ratio was 1.42 (95% CI, 0.99-2.03) in menopausal female participants and 1.45 (95% CI, 1.15-1.83) in nonmenopausal female participants compared with male participants. CONCLUSIONS AND RELEVANCE/UNASSIGNED:In this prospective cohort study of the NIH RECOVER-Adult cohort, female sex was associated with an increased risk of long COVID compared with male sex, and this association was age, pregnancy, and menopausal status dependent. These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID.
PMCID:11755195
PMID: 39841477
ISSN: 2574-3805
CID: 5778522
Increasing Colorectal Cancer Screening in an Urban Black Community: A Pilot Randomized Clinical Trial of Multilevel Interventions
Shaukat, Aasma; Das, Taranika Sarkar; Shahin, George; Hayes, Richard; Ahn, Jiyoung
PMID: 39630401
ISSN: 1573-2568
CID: 5804452
Advancing Health Equity Through Telehealth: A Systematic Review and Meta-analysis of Remote vs. In-person Weight-loss Interventions among Black Women with Obesity [Review]
Farooque, Umar; Murtaza, Meer; Umer, Muhammad; Johar, Ayesha; Aparna, Fnu; Khan, Aqsa Riaz; Kumar, Anish; Ahmed, Nazeer; Qadri, Syeda Hafsa; Idrees, Hiba; Ullah, Aman; Aliyeva, Turkan; Shaukat, Aasma
ISI:001596212800001
ISSN: 2162-4968
CID: 5966212
A Retrospective Cohort Propensity-Matched Analysis of Colorectal Cancer Risk in Isolated Small Intestinal Crohn's Disease
Alsakarneh, Saqr; Al Ta'ani, Omar; Quezada, Sandra; Raufman, Jean-Pierre; Shaukat, Aasma; Ghoz, Hassan
PMCID:12547917
PMID: 41142519
ISSN: 2772-5723
CID: 5960932
Pilot evaluation of a novel, automated ergonomics assessment tool
El Kurdi, Bara; Babar, Sumbal; Soroush, Ali; Bapaye, Jay; Wasserman, Reid D; Echavarria, Juan; Shahab, Omer; Locke, Cameron; Yang, Jamie; Koachman, Michael; Mönkemüller, Klaus; Shaukat, Aasma
BACKGROUND AND STUDY AIMS/UNASSIGNED:Gastroenterologists are prone to endoscopy-related musculoskeletal injuries (ERI). Current interventions lack real-time monitoring and feedback. ErgoGenius, a novel artificial intelligence computer-vision tool, addresses this gap by providing continuous posture assessment and feedback without wearable motion trackers. The aim of this study was to determine the feasibility of ErgoGenius, its accuracy compared with human appraisers, and its ability to detect abnormal posture. METHODS/UNASSIGNED:-test was used to compare REBA scores between bed positions. RESULTS/UNASSIGNED:= 0.006). CONCLUSIONS/UNASSIGNED:ErgoGenius was successfully deployed to detect abnormal postures related to changes in bed position and quantify ERI risk. It performed at par with human appraisers. This tool shows promise in enhancing ergonomic practices among gastroenterologists and trainees, potentially leading to better health outcomes and reduced injury.
PMCID:12080516
PMID: 40376029
ISSN: 2364-3722
CID: 5844692
Disparity in Access to Physicians With High Adenoma Detection Rates
Adenusi, Adedeji; Meng, Xucong; Bilal, Mohammad; Gross, Seth; Pochapin, Mark; Shaukat, Aasma
PMCID:12148723
PMID: 40496702
ISSN: 2772-5723
CID: 5869222
Colorectal Cancer Screening Knowledge and Associated Willingness and Barriers to Screening in Nationwide Pakistan Cohort
Kamani, Lubna; Shaikh, Tauqeer; Yousaf, Mian S; Tareen, Khalid A; Bhatti, Talal K; Bashir, Hifza; Devi, Jalpa; Akram, Muhammad; Shaukat, Aasma; Burke, Carol A
BACKGROUND/UNASSIGNED:Colorectal cancer (CRC) poses a major health challenge worldwide, specifically in developing countries, where late-stage diagnoses lead to substantial mortality rates. This study aims to evaluate CRC knowledge and screening behaviors in Pakistan while identifying barriers that hinder CRC screening uptake. MATERIALS AND METHODS/UNASSIGNED:In this cross-sectional study, a paper questionnaire was distributed to patients and companions in hospitals across all provinces in Pakistan between March 2022 and December 2023. RESULTS/UNASSIGNED:Out of 5,244 participants (68.7% male), only 23.2% claimed knowledge of CRC, while 31.5% had some awareness of it. Merely 20.1% believed CRC to be common in Pakistan. Only 6.6% of those aged 50 and above had undergone CRC screening, with 59.7% reporting no prior screening. Notably, 35.9% expressed interest in colonoscopy at age 45 for CRC screening. Screening intentions were lower in younger, female participants, and residents from Balochistan compared to their counterparts. Widowed/divorced individuals showed higher intentions than married ones. Several barriers, including a lack of screening facilities and fear of results, negatively impacted screening intentions. CONCLUSION/UNASSIGNED:Colorectal cancer awareness and screening uptake remain critically low in Pakistan, with significant barriers including a lack of knowledge, physician recommendation, and access to screening facilities. Sociodemographic factors such as age, gender, education, and region significantly influenced screening intentions. Targeted awareness efforts and improved healthcare provider engagement are essential to enhance CRC screening rates and reduce the disease burden. HOW TO CITE THIS ARTICLE/UNASSIGNED:. Colorectal Cancer Screening Knowledge and Associated Willingness and Barriers to Screening in Nationwide Pakistan Cohort. Euroasian J Hepato-Gastroenterol 2025;15(2):156-163.
PMCID:12932290
PMID: 41757146
ISSN: 2231-5047
CID: 6010512